TGR BioSciences
The Home of SureFire® & CaptSure™ Technology:
The New Gold Standard in Immunoassays
About us
TGR BioSciences is a specialist immunoassay technology company. Underpinning TGR’s immunoassays is CaptSure™ – a patented antibody immobilisation system that delivers improvements in assay speed, simplicity and performance.
Technology
Our CaptSure™ platform technology is highly amenable to multiplexing applications. TGR’s expanded platform of CaptSure™ anti-peptide antibodies can be used in various immunoassay formats such as bead-based assays, ELISA, lateral flow, immunohistochemistry and microfluidics for single or multiplex detection of analytes.
Our products
TGR’s flagship product range, AlphaLISA SureFire® Ultra™, caters for the high throughput analysis of cell-based proteins using a no-wash, bead-based technology and this extensive range of assays (>400) are widely used by pharmaceutical/biotech companies for drug discovery research. More recently, TGR has expanded its CaptSure™ technology to multiplexing with its application to SureFire® Ultra™ Multiplex.
The technology has applications in bead-based assays, ELISA, lateral flow, and microfluidics for both life sciences and diagnostics markets
TGR’s flagship product range, SureFire® Ultra™, caters for high throughput analysis of phosphoproteins using a no-wash, bead-based technology.
TGR has expanded its CaptSure™ technology to multiplexing with its application to SureFire® Ultra™ Multiplex.
TGR’s CaptSure™ ELISA assay technology underpins Abcam’s growing SimpleStep ELISA range and provides a faster and simpler workflow compared to conventional approaches. TGR’s CaptSure™ technology is available for licensing and collaboration with external parties.